Search Results - "LARSEN, S. O"

Refine Results
  1. 1

    Increased risk of preterm delivery and pre‐eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia by Naver, KV, Grinsted, J, Larsen, SO, Hedley, PL, Jørgensen, FS, Christiansen, M, Nilas, L

    “…Objective To study the risk of adverse pregnancy outcomes in women with polycystic ovary syndrome (PCOS), and to examine the role of hyperandrogenaemia. Design…”
    Get full text
    Journal Article
  2. 2

    Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk women by Wøjdemann, K. R., Shalmi, A. C., Christiansen, M., Larsen, S. O., Sundberg, K., Brocks, V., Bang, J., Nørgaard‐Pedersen, B., Tabor, A.

    Published in Ultrasound in obstetrics & gynecology (01-03-2005)
    “…Objective To determine the performance of screening for Down syndrome (DS) and other major chromosomal abnormalities using nuchal translucency (NT), free…”
    Get full text
    Journal Article
  3. 3

    Quality assessment in prospective nuchal translucency screening for Down syndrome by Wøjdemann, K. R., Christiansen, M., Sundberg, K., Larsen, S. O., Shalmi, A., Tabor, A.

    Published in Ultrasound in obstetrics & gynecology (01-12-2001)
    “…Objectives To develop and apply a quality control system in a Down syndrome screening study using nuchal translucency as an interventional marker. Methods In a…”
    Get full text
    Journal Article
  4. 4

    First trimester screening for Down syndrome and assisted reproduction: no basis for concern by Wøjdemann, K. R., Larsen, S. O., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

    Published in Prenatal diagnosis (01-07-2001)
    “…In pregnancies obtained after assisted reproduction the false‐positive rate of second trimester Down syndrome (DS) screening is increased by 1.5–3‐fold. This…”
    Get full text
    Journal Article
  5. 5

    Diagnostic assessment of haemorrhagic rash and fever by Nielsen, H E, Andersen, E A, Andersen, J, Böttiger, B, Christiansen, K M, Daugbjerg, P, Larsen, S O, Lind, I, Nir, M, Olofsson, K

    Published in Archives of disease in childhood (01-08-2001)
    “…AIMS To establish criteria for early distinction between meningococcal disease and other conditions with similar clinical features, and to identify other…”
    Get full text
    Journal Article
  6. 6

    Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia by PEDERSEN-BJERGAARD, J, PHILIP, P, LARSEN, S. O, JENSEN, G, BYRSTING, K

    Published in Blood (15-09-1990)
    “…Cytogenetic studies of 91 consecutive patients with therapy-related myelodysplasia or overt acute nonlymphocytic leukemia disclosed characteristic defects of…”
    Get full text
    Journal Article
  7. 7

    Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours by Pedersen-Bjergaard, J, Daugaard, G, Hansen, S W, Philip, P, Larsen, S O, Rørth, M

    Published in The Lancet (British edition) (10-08-1991)
    “…Among the cytostatic drugs only the alkylating agents have been firmly established as being leukaemogenic. This report describes 4 cases of acute myeloid…”
    Get more information
    Journal Article
  8. 8

    Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers by Christiansen, M, Larsen, SO, Oxvig, C, Qin, Q-P, Wagner, JM, Overgaard, MT, Gleich, GJ, Sottrup-Jensen, L, Nørgaard-Pedersen, B

    Published in Clinical genetics (01-01-2004)
    “…The efficiency of six maternal serum markers for Down's syndrome (DS), alpha fetoprotein (AFP), human chorionic gonadotropin (hCG), free β‐hCG,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A by Wøjdemann, K. R., Larsen, S. O., Rode, L., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

    “…Objective. First trimester screening for fetal chromosomal disease is now possible using the maternal serological markers pregnancy-associated plasma protein-A…”
    Get full text
    Journal Article
  11. 11

    Different Patterns of Helicobacter pylori Adherence to Gastric Mucosa Cells in Children and Adults: An Ultrastructural Study by BLOM, J, GERNOW, A, HOLCK, S, WEWER, V, NØRGAARD, A, GRAFF, L. B, KRASILNIKOFF, P. A, ANDERSEN, L. P, LARSEN, S. O

    “…Background: Infection with Helicobacter pylori in childhood may be the initiation of a lifelong coexistence between microorganisms and epithelial cells…”
    Get full text
    Journal Article
  12. 12

    Precision of risk in multidimensional likelihood ratio based screening with first trimester screening for Down's syndrome as a special case by Christiansen, M, Larsen, S O

    Published in Journal of medical screening (01-01-2001)
    “…The development of computer programs for the calculation of risks and Monte Carlo estimation of the precision of such risks in likelihood ratio based screening…”
    Get more information
    Journal Article
  13. 13

    Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers by PETERSEN, E, RØNNE, T, RØNN, A, BYGBJERG, I, LARSEN, S. O

    Published in Journal of travel medicine (01-03-2000)
    “…The aim of the study was to provide data on the relative frequency of reported symptoms in travelers using chloroquine, chloroquine plus proguanil, and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Epidemiology of classic kaposi's sarcoma in denmark between 1970 and 1992 by Hjalgrim, Henrik, Melbye, Mads, Lecker, S;ZZren, Frisch, Morten, Thomsen, Henrik Klem, Larsen, Severin Olessen

    Published in Cancer (01-04-1996)
    “…BACKGROUND Studies have suggested that the incidence of classic Kaposi's sarcoma (KS) varies considerably within Europe. The epidemiology of classic KS in…”
    Get full text
    Journal Article
  16. 16

    SCHWANGERSCHAFTSPROTEIN 1 (SP1) AS A MATERNAL SERUM MARKER FOR DOWN SYNDROME IN THE FIRST AND SECOND TRIMESTERS by QIN, Q.-P., CHRISTIANSEN, M., NGUYEN, T. H., SØRENSEN, S., LARSEN, S. O., NØRGAARD-PEDERSEN, B.

    Published in Prenatal diagnosis (01-02-1997)
    “…The potential of the maternal serum concentration of schwangerschaftsprotein 1 (MSSP1) as a marker for Down syndrome (DS) pregnancies was evaluated in the…”
    Get full text
    Journal Article
  17. 17

    Epidemiology of pertussis in Denmark: the impact of herd immunity by Nielsen, A, Larsen, S O

    Published in International journal of epidemiology (01-12-1994)
    “…An evaluation is presented of the Danish pertussis immunization programme, which consists of three injections of plain whole-cell pertussis vaccine given alone…”
    Get more information
    Journal Article
  18. 18

    Antibodies to urinary tract pathogens in patients with spinal cord lesions by MOSER, C, KRIEGBAUM, N. J, LARSEN, S. O, HØIBY, N, BIERING-SØRENSEN, F

    Published in Spinal cord (01-09-1998)
    “…Chronic or recurrent urinary tract infection (UTI) is a significant problem or patients with spinal cord lesions (SCL). UTIs are thought to be a major factor…”
    Get full text
    Journal Article
  19. 19

    Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease by Olsen, S. F., Djurhuus, B., Rasmussen, K., Joensen, H. D., Larsen, S. O., Zoffman, H., Lind, I.

    Published in Epidemiology and infection (01-06-1991)
    “…In a household survey in the Faroe Islands, an isolated community with hyperendemic occurrence of meningococcal disease due to serogroup B 15, 1604 persons…”
    Get full text
    Journal Article
  20. 20

    Management of urinary bladder function in Danish hospitals, nursing homes and home care by Zimakoff, J, Pontoppidan, B, Larsen, S O, Stickler, D J

    Published in The Journal of hospital infection (01-07-1993)
    “…The purpose of this study was to determine the prevalence of the various devices used for bladder function management in Denmark and to assess the scope for…”
    Get more information
    Journal Article